In 2018, the Rev. Jesse Jackson was among the National Civil Rights Museum's Freedom Award honorees. Jackson, who died Feb. 17 at the age of 84, traveled to Memphis for the Freedom Award ceremony in ...

British pharmaceutical group GSK reported Wednesday a sharp rise in annual net profit, boosted by strong sales of HIV, respiratory and cancer treatments as it recovered from costly US lawsuits over ...

As the Acetaminophen-Autism appeal advances in the Second Circuit—where plaintiffs contend that Judge Denise Cote wrongly excluded their experts and dismissed their claims—another 50,000 Zantac ...

Interest rates range from around 5% to 14% for commercial real estate loans. But your specific rate will depend on lots of factors, such as the loan type, property and your creditworthiness. Many, or ...

Some Delaware Supreme Court justices signaled they may be skeptical of a bid by GSK Plc, Pfizer Inc. and other drugmakers to overturn a judge who allowed more than 80,000 lawsuits to proceed to trial ...

The Commercial Integration Cell is part of the U.S. Space Force's Combined Operations Center, pictured here. (Tech. Sgt Luke Kitterman/U.S. Space Force) The Space Force added five companies to its ...

Earlier this week, GSK plc (NYSE:GSK) reached agreements with ten plaintiff firms representing approximately 80,000 Zantac product liability cases in the U.S. state courts. These cases account for 93% ...

Nisha Gopalan is a former Senior Overnight Assignment Editor for Investopedia News. She is an award-winning financial journalist who has worked in London, where she is currently based, and Hong Kong.

GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion. By Rebecca Robbins The British drug maker GSK said on Wednesday that it ...

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on ...